Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Bob D Brown. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Bob D Brown har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:DRNA / Dicerna Pharmaceuticals Inc Chief Scientific Ofr., EVP R&D 0
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Bob D Brown. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Bob D Brown som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2021-12-29 2021-12-28 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
D - Sale to Issuer -68.100 0 -100,00
2021-12-29 2021-12-28 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
D - Sale to Issuer -121.300 0 -100,00
2021-12-29 2021-12-28 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
D - Sale to Issuer -75.000 0 -100,00
2021-12-29 2021-12-28 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
D - Sale to Issuer -165.050 0 -100,00
2021-12-29 2021-12-28 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
D - Sale to Issuer -180.000 0 -100,00
2021-12-29 2021-12-28 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
D - Sale to Issuer -105.000 0 -100,00
2021-12-29 2021-12-28 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
D - Sale to Issuer -85.000 0 -100,00
2021-12-29 2021-12-28 4 DRNA Dicerna Pharmaceuticals Inc
Restricted Stock Units
D - Sale to Issuer -11.325 0 -100,00
2021-12-29 2021-12-28 4 DRNA Dicerna Pharmaceuticals Inc
Restricted Stock Units
D - Sale to Issuer -25.950 0 -100,00
2021-12-29 2021-12-28 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
U - Other -2.367 0 -100,00 38,25 -90.538
2021-12-17 2021-12-15 4 DRNA Dicerna Pharmaceuticals Inc
Restricted Stock Units
M - Exercise -3.775 11.325 -25,00
2021-12-17 2021-12-15 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
F - Taxes -1.675 2.367 -41,44 38,05 -63.734 90.064
2021-12-17 2021-12-15 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 3.775 4.042 1.413,86
2021-11-22 2021-11-18 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -24.936 0 -100,00
2021-11-22 2021-11-18 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -24.936 267 -98,94 37,94 -946.072 10.130
2021-11-22 2021-11-18 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 24.936 25.203 9.339,33 3,42 85.281 86.194
2021-09-21 2021-09-17 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -21.250 267 -98,76 21,06 -447.516 5.623
2021-08-03 2021-08-02 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -8.312 24.936 -25,00
2021-08-03 2021-08-02 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -8.312 21.517 -27,87 37,38 -310.678 804.241
2021-08-03 2021-08-02 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 8.312 29.829 38,63 3,42 28.427 102.015
2021-07-06 2021-07-01 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -8.312 33.248 -20,00
2021-07-06 2021-07-01 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -1.066 21.517 -4,72 37,85 -40.344 814.345
2021-07-06 2021-07-01 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -7.246 22.583 -24,29 37,30 -270.297 842.411
2021-07-06 2021-07-01 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 8.312 29.829 38,63 3,42 28.427 102.015
2021-06-15 2021-06-11 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -10.000 85.000 -10,53
2021-06-15 2021-06-11 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -10.000 21.517 -31,73 34,00 -340.000 731.578
2021-06-15 2021-06-11 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 10.000 31.517 46,47 9,09 90.900 286.490
2021-06-08 2021-06-07 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -10.000 95.000 -9,52
2021-06-08 2021-06-07 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -10.000 21.517 -31,73 33,00 -330.000 710.061
2021-06-08 2021-06-07 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 10.000 31.517 46,47 9,09 90.900 286.490
2021-06-03 2021-06-01 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -8.312 41.560 -16,67
2021-06-03 2021-06-01 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -342 21.517 -1,56 32,02 -10.950 688.899
2021-06-03 2021-06-01 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -7.970 21.859 -26,72 30,88 -246.128 675.045
2021-06-03 2021-06-01 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 8.312 29.829 38,63 3,42 28.427 102.015
2021-05-05 2021-05-03 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -8.312 49.872 -14,29
2021-05-05 2021-05-03 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -24 21.517 -0,11 31,66 -760 681.228
2021-05-05 2021-05-03 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -1.135 21.541 -5,01 31,01 -35.197 667.993
2021-05-05 2021-05-03 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -7.153 22.676 -23,98 30,16 -215.716 683.849
2021-05-05 2021-05-03 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 8.312 29.829 38,63 3,42 28.427 102.015
2021-05-03 2021-04-30 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -10.000 105.000 -8,70
2021-05-03 2021-04-30 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -10.000 21.517 -31,73 32,00 -320.000 688.544
2021-05-03 2021-04-30 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 10.000 31.517 46,47 9,09 90.900 286.490
2021-05-03 2021-04-29 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -10.000 115.000 -8,00
2021-05-03 2021-04-29 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -10.000 21.517 -31,73 31,00 -310.000 667.027
2021-05-03 2021-04-29 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 10.000 31.517 46,47 9,09 90.900 286.490
2021-04-05 2021-01-25 4/A DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -16.630 5.246 -76,02
2021-04-05 2021-01-25 4/A DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 16.630 43.147 62,71 2,97 49.391 128.147
2021-04-05 2021-02-03 4/A DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -5.246 0 -100,00
2021-04-05 2021-02-03 4/A DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -3.066 74.808 -3,94
2021-04-05 2021-02-03 4/A DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 5.246 29.829 21,34 2,97 15.581 88.592
2021-04-05 2021-02-03 4/A DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 3.066 24.583 14,25 3,42 10.486 84.074
2021-04-05 2021-03-01 4/A DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -8.312 66.496 -11,11
2021-04-05 2021-03-01 4/A DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 8.312 29.829 38,63 3,42 28.427 102.015
2021-04-05 2021-04-01 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -8.312 58.184 -12,50
2021-04-05 2021-04-01 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -188 21.517 -0,87 26,50 -4.981 570.093
2021-04-05 2021-04-01 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -8.124 21.705 -27,24 25,85 -210.044 561.178
2021-04-05 2021-04-01 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 8.312 29.829 38,63 3,42 28.427 102.015
2021-03-02 2021-03-01 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -8.312 91.746 -8,31
2021-03-02 2021-03-01 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -783 21.517 -3,51 29,49 -23.090 634.513
2021-03-02 2021-03-01 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -7.529 22.300 -25,24 28,90 -217.611 644.539
2021-03-02 2021-03-01 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 8.312 29.829 38,63 9,09 75.556 271.146
2021-02-04 2021-02-03 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -8.312 100.058 -7,67
2021-02-04 2021-02-03 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -8.312 21.517 -27,87 25,00 -207.800 537.925
2021-02-04 2021-02-03 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 8.312 29.829 38,63 9,09 75.556 271.146
2021-01-27 2021-01-25 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -16.630 108.370 -13,30
2021-01-27 2021-01-25 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -21.630 21.517 -50,13 25,00 -540.750 537.925
2021-01-27 2021-01-25 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 16.630 43.147 62,71 9,09 151.167 392.206
2021-01-13 2021-01-12 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -5.808 26.517 -17,97 24,07 -139.817 638.349
2021-01-12 2021-01-12 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
A - Award 68.100 68.100
2021-01-12 2021-01-12 4 DRNA Dicerna Pharmaceuticals Inc
Restricted Stock Units
A - Award 15.100 15.100
2021-01-12 2021-01-08 4 DRNA Dicerna Pharmaceuticals Inc
Restricted Stock Units
M - Exercise -8.650 25.950 -25,00
2021-01-12 2021-01-08 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
F - Taxes -2.842 32.325 -8,08 23,29 -66.190 752.849
2021-01-12 2021-01-08 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 8.650 35.167 32,62
2020-12-03 2020-12-01 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -8.185 0 -100,00
2020-12-03 2020-12-01 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -8.185 26.517 -23,59 25,19 -206.206 668.045
2020-12-03 2020-12-01 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 8.185 34.702 30,87 3,42 27.993 118.681
2020-11-03 2020-11-02 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -8.185 8.185 -50,00
2020-11-03 2020-11-02 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -8.185 26.517 -23,59 21,03 -172.131 557.653
2020-11-03 2020-11-02 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 8.185 34.702 30,87 3,42 27.993 118.681
2020-10-20 2020-10-16 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -16.370 16.370 -50,00
2020-10-20 2020-10-16 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -16.370 26.517 -38,17 21,00 -343.770 556.857
2020-10-20 2020-10-16 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 16.370 42.887 61,73 3,42 55.985 146.674
2020-09-18 2020-09-16 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -21.250 77.874 -21,44
2020-09-18 2020-09-16 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 21.250 26.517 403,46 3,42 72.675 90.688
2020-09-16 2020-09-14 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -267 0 -100,00
2020-09-16 2020-09-14 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 267 5.267 5,34 3,42 913 18.013
2020-08-05 2020-08-03 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -8.185 32.740 -20,00
2020-08-05 2020-08-03 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -2.521 5.000 -33,52 22,80 -57.479 114.000
2020-08-05 2020-08-03 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -5.664 7.521 -42,96 22,34 -126.508 167.985
2020-08-05 2020-08-03 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 8.185 13.185 163,70 3,42 27.993 45.093
2020-07-06 2020-07-01 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -8.185 40.925 -16,67
2020-07-06 2020-07-01 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -2.371 5.000 -32,17 26,85 -63.669 134.266
2020-07-06 2020-07-01 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -5.814 7.371 -44,10 26,36 -153.259 194.303
2020-07-06 2020-07-01 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 8.185 13.185 163,70 3,42 27.993 45.093
2020-06-23 2020-06-19 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -9.670 21.876 -30,65
2020-06-23 2020-06-19 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -9.670 5.000 -65,92 25,00 -241.750 125.000
2020-06-23 2020-06-19 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 9.670 14.670 193,40 2,97 28.720 43.570
2020-06-02 2020-06-01 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -8.185 49.110 -14,29
2020-06-02 2020-06-01 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -8.185 5.000 -62,08 21,01 -171.959 105.046
2020-06-02 2020-06-01 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 8.185 13.185 163,70 3,42 27.993 45.093
2020-05-12 2020-05-11 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -13.281 31.546 -29,63
2020-05-12 2020-05-11 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -13.281 5.000 -72,65 24,00 -318.744 120.000
2020-05-12 2020-05-11 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 13.281 18.281 265,62 2,97 39.445 54.295
2020-05-07 2020-05-05 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -8.185 57.295 -12,50
2020-05-07 2020-05-05 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -8.185 5.000 -62,08 21,00 -171.885 105.000
2020-05-07 2020-05-05 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 8.185 13.185 163,70 3,42 27.993 45.093
2020-04-21 2020-04-20 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -13.281 44.827 -22,86
2020-04-21 2020-04-20 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -13.281 5.000 -72,65 23,00 -305.463 115.000
2020-04-21 2020-04-20 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 13.281 18.281 265,62 2,97 39.445 54.295
2020-04-21 2020-04-17 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -8.185 65.480 -11,11
2020-04-21 2020-04-17 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -8.185 5.000 -62,08 21,18 -173.358 105.900
2020-04-21 2020-04-17 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 8.185 13.185 163,70 3,42 27.993 45.093
2020-03-03 2020-03-02 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -8.185 73.665 -10,00
2020-03-03 2020-03-02 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -8.185 5.000 -62,08 21,00 -171.885 105.000
2020-03-03 2020-03-02 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 8.185 13.185 163,70 3,42 27.993 45.093
2020-02-11 2020-02-10 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -2.535 99.124 -2,49
2020-02-11 2020-02-10 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -5.650 81.850 -6,46
2020-02-11 2020-02-10 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -8.185 5.000 -62,08 21,00 -171.885 105.000
2020-02-11 2020-02-10 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 2.535 13.185 23,80 3,42 8.670 45.093
2020-02-11 2020-02-10 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 5.650 10.650 113,00 3,42 19.323 36.423
2020-01-10 2020-01-08 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
A - Award 121.300 121.300
2020-01-10 2020-01-08 4 DRNA Dicerna Pharmaceuticals Inc
Restricted Stock Units
A - Award 34.600 34.600
2019-12-31 2019-12-31 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -11.941 58.108 -17,05
2019-12-31 2019-12-31 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -5.000 101.659 -4,69
2019-12-31 2019-12-31 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -11.941 5.000 -70,49 22,00 -262.702 110.000
2019-12-31 2019-12-31 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 11.941 16.941 238,82 2,97 35.465 50.315
2019-12-31 2019-12-31 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 5.000 5.000 3,42 17.100 17.100
2019-12-31 2019-12-30 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -4.951 70.049 -6,60
2019-12-31 2019-12-30 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -8.185 106.659 -7,13
2019-12-31 2019-12-30 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -1.340 0 -100,00 22,01 -29.487
2019-12-31 2019-12-30 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -21.466 1.340 -94,12 21,84 -468.914 29.272
2019-12-31 2019-12-30 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 4.951 22.806 27,73 2,97 14.704 67.734
2019-12-31 2019-12-30 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 8.185 17.855 84,64 3,42 27.993 61.064
2019-01-04 2019-01-02 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
A - Award 180.000 180.000
2018-05-11 2018-05-09 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -9.669 9.670 -50,00 15,00 -145.035 145.050
2018-01-08 2018-01-04 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
A - Award 105.000 105.000
2017-01-05 2017-01-03 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy
A - Award 75.000 75.000
2016-01-12 2016-01-08 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
A - Award 125.000 125.000
2015-01-13 2015-01-09 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
A - Award 75.000 75.000
2014-04-18 2014-04-16 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (right to buy)
A - Award 165.050 165.050
2014-01-29 3 DRNA Dicerna Pharmaceuticals Inc
Common Stock
19.339
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)